Cite
Neoadjuvant Chemotherapy in Patients with HER2- Negative Breast Cancer: A Report from Clinical Breast Cancer Registry of Iran.
MLA
Roudini, Kamran, et al. “Neoadjuvant Chemotherapy in Patients with HER2- Negative Breast Cancer: A Report from Clinical Breast Cancer Registry of Iran.” Archives of Iranian Medicine (AIM), vol. 27, no. 4, Apr. 2024, pp. 206–15. EBSCOhost, https://doi.org/10.34172/aim.2024.30.
APA
Roudini, K., Mirzania, M., Yavari, T., Seyyedsalehi, M. S., Nahvijou, A., Zebardast, J., Saadat, M., & Khajeh-Mehrizi, A. (2024). Neoadjuvant Chemotherapy in Patients with HER2- Negative Breast Cancer: A Report from Clinical Breast Cancer Registry of Iran. Archives of Iranian Medicine (AIM), 27(4), 206–215. https://doi.org/10.34172/aim.2024.30
Chicago
Roudini, Kamran, Mehrzad Mirzania, Tahereh Yavari, Monireh Sadat Seyyedsalehi, Azin Nahvijou, Jayran Zebardast, Mina Saadat, and Ahmad Khajeh-Mehrizi. 2024. “Neoadjuvant Chemotherapy in Patients with HER2- Negative Breast Cancer: A Report from Clinical Breast Cancer Registry of Iran.” Archives of Iranian Medicine (AIM) 27 (4): 206–15. doi:10.34172/aim.2024.30.